Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Publisher: Elsevier · ISSN 2405-5794 · 43 articles
- Tb-free Majuro: Results from community-wide tuberculosis screening and treatment in the Marshall Islands
- Therapeutic drug monitoring of first-line anti-tuberculosis drugs: impact of dose modification on plasma drug concentrations in pulmonary and extrapulmonary tuberculosis
- Development of a diagnostic nomogram for tuberculous pleural effusion
- The critical link between clinical risk stratification and pharmacovigilance in tuberculosis therapy: implications for rifampicin-induced cholestatic jaundice
- Comment on “Prevalence and risk factors associated with rifampicin-induced cholestasis jaundice among tuberculosis patients in high-incidence setting: A retrospective cohort study”
- Prevalence of Long COVID in Mycobacterium tuberculosis-exposed groups
- Host genetic polymorphisms, immune response, and susceptibility to pleural tuberculosis: A systematic review
- Comments on “Prevalence and risk factors associated with rifampicin-induced cholestasis jaundice among tuberculosis patients in high-incidence setting: a retrospective cohort study”
- Evaluation of the laboratory performance of MolecuTech®REBA MTB-MDR kit for the detection of multidrug resistant tuberculosis
- Proportions of M. Intracellulare and M. Avium among non-tuberculous mycobacteria isolates in China: A Systematic review and Meta-Analysis
- Analysis of the differential clinical characteristics of tuberculosis and nontuberculous mycobacterial diseases among AIDS patients
- Illicit substance use and its impact on tuberculosis care engagement: A systematic review and Meta-analysis of prevalence
- Efficacy and safety of an intravenous amikacin-containing regimen as initial therapy in Mycobacterium avium complex pulmonary disease
- Acetylator status-guided rapid reintroduction of isoniazid in tuberculosis patients with drug-induced hepatotoxicity
- Closing gaps through innovation in the tuberculosis pathology value chain
- Epidemiology of extrapulmonary tuberculosis, Alameda County, California, 2010–2021
- Real-world challenges of 4-month rifapentine-moxifloxacin TB regimen: High hyperbilirubinemia in Thailand
- A diagnostic nomogram for tuberculous pleural effusion: Methodological considerations
- Tuberculosis treatment and cytotoxic immune signatures: a longitudinal study
- Evolution of evidence on vitamin D supplementation in tuberculosis: A comprehensive umbrella review of nine systematic reviews
- Challenges in tuberculosis screening before TNF-α inhibitors: A case report highlighting gaps in current practice
- Private sector engagement in tuberculosis detection: a bibliometric analysis
- Performance of the BACES model in a Dutch cohort with nontuberculous mycobacterial pulmonary disease
- Serum tuberculosis biomarkers and their association with clinical characteristics among hospitalized adults living with HIV in Uganda
- Tuberculin responsiveness as a surrogate prognostic marker in hospitalized HIV-infected patients with tuberculosis in a resource-limited setting
- Developing an integrated medication event monitoring system and smartphone-based ecological momentary assessment delivery platform to identify real-time factors influencing TB treatment adherence in South Africa
- Public transport: the missing link in tuberculosis control in Somalia
- Key risk factors for pulmonary vs. extrapulmonary tuberculosis: a comparative study in Southwest Ethiopia
- Knowledge, attitudes, and perceived barriers to tuberculosis care among patients and household contacts in Wolisso District, Oromia Region, Ethiopia
- Lung ultrasound and the interstitial syndrome in tuberculosis endemic regions: illustrated insights from diverse clinical settings